Guidelines for Managing Stimulant Use Disorder: Applying a Pregnancy and Postpartum Lens

Friday, April 25, 2025

10:30 AM – 11:45 AM

Presenter(s)

Niraj R. Chavan, MD, MPH, FACOG, FASAM

Associate Professor, Fellowship Director
Saint Louis University / SSM Health
Saint Louis, Missouri
Cresta W. Jones, MD, FACOG, FASAM

Associate Professor
University of Minnesota Medical School
Eden Prairie, Minnesota
Maria Manriquez, MD, FASAM, FACOG

Professor, Fellowship Associate Program Director
University of Arizona College of Medicine - Phoenix
Phoenix, Arizona

This focus session will review the ASAM/AAAP guidelines for management of stimulant use disorder (StUD) in the context of perinatal populations and highlight key physiological considerations and implications for maternal and neonatal wellbeing that may impact treatment choices. This session will address a critical knowledge and practice gap, as it pertains to the skill set needed for managing perinatal StUD with the ultimate goal of expanding the clinical workforce that could effectively manage stimulant use among pregnant and parenting persons.

Learning Objectives:

Learners will be able to:

Discuss the recent ASAM / AAAP guidelines for the management of stimulant use disorder (StUD) including clinical scenarios involving acute intoxication and withdrawal from stimulants, specifically as it applies to birthing persons.
Recognize the key physiologic and pharmacologic considerations relevant to the management of StUD in pregnancy and postpartum period and apply these to medication choices and recommendations.
Formulate well-rounded treatment plans for commonly encountered clinical scenarios involving stimulant use during pregnancy and postpartum, incorporating principles of perinatal harm reduction.

Disclosure(s):

Niraj R. Chavan, MD, MPH, FACOG, FASAM: No financial relationships to disclose

Cresta W. Jones, MD FACOG FASAM: No financial relationships to disclose

Maria Manriquez, MD, FASAM, FACOG: No financial relationships to disclose